Publication | Closed Access

Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model

NanomedicineDrug TargetingEngineeringLung InflammationMedicinePulmonary PharmacologyPulmonary FibrosisNano-drug DeliveryBiomedical EngineeringPharmacologyProtein NanoparticlesTherapeutic Advantage